Back to mobile site

AtriCure (ATRC) Tops Q2 EPS by 5c

July 27, 2017 4:07 PM EDT

AtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.21), $0.05 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $45.2 million versus the consensus estimate of $44.21 million.

For earnings history and earnings-related data on AtriCure (ATRC) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings